Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1700991000001112 | Belantamab mafodotin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1701001000001111 | Belantamab mafodotin (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belantamab mafodotin | Is a | Antineoplastic agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belantamab mafodotin 100mg powder for solution for infusion vials | Has specific active ingredient | False | Belantamab mafodotin | Inferred relationship | Existential restriction modifier | |
| Blenrep 100mg powder for concentrate for solution for infusion vials (Imported (Ireland)) 1 vial | Has specific active ingredient | False | Belantamab mafodotin | Inferred relationship | Existential restriction modifier | |
| Blenrep 100mg powder for concentrate for solution for infusion vials (Imported (Ireland)) | Has specific active ingredient | False | Belantamab mafodotin | Inferred relationship | Existential restriction modifier | |
| Belantamab mafodotin 100mg powder for solution for infusion vials 1 vial | Has specific active ingredient | False | Belantamab mafodotin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR